Related Experiment Video
Updated: Mar 27, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Neurobiological links between Alzheimer's disease and reward system dysfunction
Hasmik Harutyunyan1, Ruben Minasyan1, Allan V Kalueff2
1Neuroscience Laboratory, COBRAIN Center, Yerevan State Medical University Named After Mkhitar Heratsi, Yerevan 0025, Armenia.
Alzheimer's disease (AD) involves early brain changes affecting reward circuits. Targeting these reward pathways may offer new therapeutic strategies for AD patients experiencing motivational deficits.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with unknown causes and limited treatments.
- Early AD pathology involves amyloid-β, neurofibrillary tangles, neuroinflammation, and neuronal loss.
- Reward system dysfunction is common in AD patients and models, manifesting as apathy and anhedonia.
Purpose of the Study:
- To explore the neuroanatomical, neurochemical, and molecular links between AD pathology and reward circuits.
- To propose that reward system dysfunction is a key endophenotype in AD pathogenesis.
- To identify potential therapeutic targets within reward-related circuits for AD.
Main Methods:
- Review of neuroanatomical, neurochemical, and molecular data.
- Analysis of shared pathways between AD progression and reward circuitry.
- Conceptual framework development linking AD and reward system dysfunction.
Main Results:
- Significant overlap exists between brain regions affected by AD and those involved in reward processing.
- Reward system dysfunction, including apathy and anhedonia, is a frequent characteristic of AD.
- Dysfunction of the brain's reward system may be an integral part of AD's pathological process.
Conclusions:
- Reward system dysfunction is a significant endophenotype of Alzheimer's disease.
- Understanding the interplay between AD and reward circuits can refine AD conceptualization.
- Targeting reward-related circuits offers a promising avenue for novel AD therapeutic strategies.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Neural Regulation
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Alzheimer's Disease: Treatment
Olfaction
The olfactory receptors are embedded in the cilia of the...

